Wird geladen...

Studies on Fragment-Based Design of Allosteric Inhibitors of Human Factor XIa

Human factor XIa (hFXIa) has emerged as an attractive target for development of new anticoagulants that promise higher level of safety. Different strategies have been adopted so far for the design of anti-hFXIa molecules including competitive and non-competitive inhibition. Of these, allosteric dysf...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorg Med Chem
Hauptverfasser: Boothello, Rio S., Sankaranarayanan, Nehru Viji, Afosah, Daniel K., Karuturi, Rajesh, Al-Horani, Rami A., Desai, Umesh R.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2020
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8109618/
https://ncbi.nlm.nih.gov/pubmed/32992249
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bmc.2020.115762
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!